Cooperation in the field of toxicology, analytics, R&D and production

Similar documents
Data Requirements for New Chemical Notification in China Please go to for more info about China REACH

Integrated Testing Strategies for REACH. Perspective from the European Chemicals Agency

Guidance Documents for New Chemical Substance Notification in China (China REACH) Non Official

Is your next regulatory deadline within REACH?

Medical Devices INNOVATIVE SOLUTION FOR THE HEALTHCARE

REACH Services. Global Service Provider to the Chemical Industry

Testing of chemicals for classification according to REACH and GHS

Testing of chemicals for classification according to REACH and GHS

Biocompatibility: a risk based approach

Guidance on applications for technical equivalence

Get ready for Meeting your information requirements. 11 th Stakeholder s Day. 25 May 2016

Documentation requirements for an initial consultation

GUIDANCE DOCUMENT ON APPLICATIONS FOR TECHNICAL EQUIVALENCE

Structure and content of an IMPD. What is required for first into man trial?

Dr. Annelie Struessmann Technical Director, CONUSBAT Johannesburg, 16. October 2012

Consultation by a notified body on an ancillary medicinal substance integrated in a medical device

Guidance on the Biocidal Products Regulation

Practical guide for SME managers and REACH coordinators. How to fulfil your information requirements at tonnages 1-10 and tonnes per year

Public Interest Incorporated Foundation BioSafety Research Center

DISCOVER OUR SEGMENT CHEMICALS/ REACH

Colorants in Medical Devices:

- A6/18 - Format for the listing of test and study reports and other documentation PART 4

GPS Safety Summary. Hexylene glycol

Switzerland EXPERTS TAKING CARE

According to BPR Article 19 and Annex II, information on analytical methods is required

A Global Reference in Laboratory Testing. Laboratory excellence to support your testing of biocidal products, detergents and biopesticides

MALAYSIA S NATIONAL PROJECT TO GATHER PRIMARY SAFETY DATA FOR NANO-BASED PRODUCTS IN THE LOCAL MARKET

ACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY

REGULATORY ASSURANCE R&D SUPPORT

Approval process for veterinary medicinal products in Japan

David Owen Shell Chemicals Ltd ISRTP Workshop, Baltimore November 2005

How ECHA identifies the design for the extended one-generation reproductive toxicity study (EOGRTS) under dossier evaluation.

Precision. Proficiency. Proximity.

REACH 2018 Registration Deadline

News Release. Even more attractive to life science and fine chemical industries. Saltigo at CPhI 2017, Frankfurt, October 24-26, 2017, Stand 111H21

ISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances

Best-in-class API / HPAPI / Small Molecules Custom Manufacturing

Biological evaluation of medical devices --

CASE STUDYS: APPLYING ALTERNATIVE APPROACHES

PHARMACEUTICAL TESTING

Medical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark

Accredited Laboratory

Guidance on the Biocidal Products Regulation

Quality assurance at a high level

Registration of. Proprietary Chinese Medicine!

REACH 2018 Steps to a Successful Registration. Thursday, October 8, 2015

COMMISSION REGULATION (EU) / of

CTA/NDA Regulatory Landscape in China. Jack Xie, PhD, DABT SOT 2016

Jubilant Life Sciences Ltd. with its strong Medicinal, Synthetic, Organic Chemistry and

Testing Methods and Directives

DISCOVER OUR SEGMENT REGULATORY SCIENCE

Know-how and Best Practice to Serve our Clients

1. INTRODUCTION TO HANDBOOK 5

SAFETY RESEARCH INSTITUTE FOR CHEMICAL COMPOUNDS CO., LTD.

Impact factor: 3.958/ICV: 4.10 ISSN:

Registration data and dossier handling

Non-clinical documentation Overview of Requirements

Services for Medical Devices. Expert solutions for product development from concept to commercialization

Design and Implementation of a Small Footprint Continuous API facility for Portfolio Commercialization. Eoin McManus Eli Lilly and Company March 2016

Risk Management of Biological Evaluation What s the Future for ISO 10993?

EXECUTIVE SUMMARY. Technical Aspects of Enzymes (Chapter 3)

ISO/TS TECHNICAL SPECIFICATION

Guideline on the non-clinical requirements for radiopharmaceuticals

GPS Safety Summary. 4-methylpentan-2-one

GB/T / ISO :2007

LAB EXPERTS AT YOUR SIDE Over twenty years of experience

4 Principles for the valuation of the biological evaluation of materials and medical devices

Cost Reduction in REACH Alternatives to Testing ChemicalWatch EXPO Berlin, April 2017 Peter Jenkinson CEHTRA

Dossier for marketing authorization in the European Union

Radglo ICE TECHNICAL DATA SHEET 13/03/2019. General information. Fluorescent colors:

Lonza Nansha, China For Global Excellence in Advanced Chemical Synthesis

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

-REACH - Hazard Data: Requirements and Closing Gaps

ISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 2: Animal welfare requirements

Registration of Proprietary Chinese Medicine!

Biocompatibility Testing for Medical Devices

Biocompatibility Testing for Medical Devices

Justification Document for the Selection of a CoRAP Substance - Update -

Recommendations for registrants to improve data quality in registration dossiers for chemicals 1000 tpa Based on the project REACH Compliance

Guidance on the Biocidal Products Regulation

Drug Impurities: The Good, Bad and Ugly

EURL ECVAM. A broader role for greater impact. Maurice Whelan. Head of Systems Toxicology Unit and EURL ECVAM

AGREEMENT OF THE MEMBER STATE COMMITTEE ON THE IDENTIFICATION OF PENTADECAFLUOROOCTANOIC ACID (PFOA) AS A SUBSTANCE OF VERY HIGH CONCERN

IUCLID 5 COMPOSITION AND ANALYSIS GUIDANCE DOCUMENT:

Substances characterization & (eco)toxicity

Global Product Safety Summary. Dodecan-1-ol

GPS Safety Summary Buta-1,3-diene

GPS Safety Summary Propene

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Guidance for Industry

ISO/TS TECHNICAL SPECIFICATION

Testing and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval

Laboratory Reagents and Raw Materials for Production.

TABLE OF CONTENTS. 1. Introduction

Please find below the Commission Communication and the Commission Recommendation for the substance

Restricted Substance List (RSL) Medical Devices

DRUG REGISTRATION REGULATION

The European Union REACH regulation was adopted

Technical Notes for Guidance. on the assessment of technical equivalence of substances regulated under Directive 98/8/EC

Transcription:

Cooperation in the field of toxicology, analytics, R&D and production

Where you can find us 2 2 VUOS PARTNER FOR COOPERATION

History 3 3 VUOS PARTNER FOR COOPERATION

Organizational structure 1. R&D and Production of Fine Chemicals 2. Toxicology and Analytics 4 14 10 6 Education structure of employees Skilled 25 % 70 Secondary 30% University degree 36% Ph.D. degree 9% Number of Employees 4 VUOS PARTNER FOR COOPERATION

What can VUOS offer Research Development Scaling up Production from gram to MT Analytics Testing of new chemicals Registration according to REACH legislative State-of-the-art equipment Experienced staff 5 5 VUOS PARTNER FOR COOPERATION

R&D Pharmaceutical intermediates Intermediates for microelectronics Custom syntheses of chemical specialities 6 Dyes and pigments for special application Activity in the field of heterocycles and API Building Blocks And many other areas 6 VUOS PARTNER FOR COOPERATION

Selection of technologies (I) Organometallic and Cryogenic Chemistry Organolithium Chemistry Organozinc Chemistry Grignards Sodium Hydride Reactions 7 Transition-Metal Catalysis Homogeneous and Heterogeneous Transition-Metal Catalysis Cross Couplings (Suzuki, Kumada, Heck, etc.) 7 VUOS PARTNER FOR COOPERATION

Selection of technologies (II) Hazardous and Unpleasant Chemistry Phosgenation Halogenation (PCl3, POCl3, SOCl2, BCl3, BBr3, etc.) Rections with Nitroalkanes Nitration Sulfonation 8 VUOS PARTNER FOR COOPERATION 8 Reduction and High-Pressure Hydrogenations Reduction with Sodium borohydride, Red-Al, Superhydride, etc. Reductive Alkylation Reductive Amination Hydrogenolysis Dehalogenation And many other areas

R&D, upscaling Wide range of quantities Grams in laboratory 9 Kilograms in kilolab unit Metric tons in VUOS production plant Hundreds of MT Synthesia, a.s. 9 VUOS PARTNER FOR COOPERATION

Kilolab and Semi-Pilot Unit Phosgenation Reactors up to 1 600 l Hydrogenation Autoclaves up to 1 000 l Temperature max. 200 C Pressure max.130 bar 10 Multipurpose chemistry Low temperature, RLi, RMgX, NaH Reactors 650 l, 400 l and 60 l cooled down to - 80 C 20x glass reactors, 100 l each 6x glass lined reactors up to 1 500 l 2x evaporators 50 l/h 4x stainless steel reactors up to 1500 l Sufficient filtration and distillation capacity 10 VUOS PARTNER FOR COOPERATION

Production Unit Production Equipment 45 x glass lined reactors, total vol. 85 000 l (500 6 000 l) 16 x stainless steel reactors, 11 total vol. 29 000 l (1 000 6 000 l) 8 x High performance rectification columns sufficient filtration capacity (nutsches, centrifuges) computer controlled 11 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Spheres of Activities: Industrial Chemicals (REACH) Pesticides and Biocides Pharmaceuticals Medical Devices Cosmetics Quality Control 12 12 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Industrial Chemicals (REACH) Toxicological testing In vivo and in vitro tests according to the OECD or EU methods Acute toxicity Skin and Eye irritation Skin sensitisation Repeated dose toxicity Reproductive toxicity Carcinogenicity Mutagenicity In vitro tests others 13 13 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Industrial Chemicals (REACH) Ecotoxicological testing Aquatic toxicity Biotic degradation Abiotic degradation Adsorption/desorption 14 Physico-chemical testing Information on physico-chemical properties of substance 14 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Industrial Chemicals (REACH) REACH and CLP Services Literature search Preparation of dossiers in IUCLID 5 Chemical Safety Assessment Non-testing approaches (Q)SAR Grouping/Read-across Preparation of esds Classification and Labelling 15 Experience from registration 2010 and 2013 15 Lead registrant s dossiers for substance on its own More than 50 dossiers of Member of Joint submission 15 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Pesticides and Biocides Toxicology and toxicokinetics Characterization of pesticides Field trials and efficacy testing (partner facility) Anti-counterfeit effort analyses Physico-chemical tests 16 5-batch analysis Stability studies Trace and ultra-trace analysis Structure identification Method development and validation 16 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Pharmaceuticals Non-clinical safety testing Reproductive and Developmental Toxicity Single-Dose Toxicity Repeated-Dose Toxicity Genotoxicity Carcinogenicity Local Tolerance Bioanalytics (partner facility) In vitro models 17 17 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Medical Devices Biocompatibility testing according to EN ISO 10993 guidelines in conformity with EN ISO/IEC 17025:2005 Tests for genotoxicity, carcinogenicity and reproductive toxicity Tests for local effects after implantation 18 Tests for irritation and delayed-type hypersensitivity Tests for systemic toxicity Cosmetics In vitro tests for skin and eye irritation Genotoxicity Cytotoxicity 18 VUOS PARTNER FOR COOPERATION

Toxicology, Ecology and Analytics Quality Control Analytical Services NMR Spectrometry Mass Spectrometry (LC/GC-MS) ICP-AES IR Spectrometry 19 Chromatography (HPLC, GC) UV-VIS Method development and validation USP & Ph. Eur. Methods 19 VUOS PARTNER FOR COOPERATION

The Certificates of VUOS Certificates of Good Laboratory Practice (GLP) Certificate on Compliance with Principles of Good Manufacturing Practice in laboratory (GMP) 20 Certificate of Accreditation No. 230/2002 Testing Laboratory No. 1057 (EN ISO/IEC 17025:2005) ISO 9001:2008 20 VUOS PARTNER FOR COOPERATION

Certificates issued by CETA (September 2014 - March 2015) 4 % 7 % 47 % 21 42 % ISO 17025 GMP GLP Product certification 21 VUOS PARTNER FOR COOPERATION

What s new in VUOS (I) Amendment of REACH annexes VIII, IX and X by ECHA (13 March 2015) two-generation reproductive toxicity study (EU B.35, OECD TG 416) 22 replaced by Extended one-generation reproductive toxicity study (EOGRTS, EU B.56, OECD TG 443) 22 VUOS PARTNER FOR COOPERATION

What s new in VUOS (II) HPLC MS Identification and determination 23 of unknown substances (non- target analysis) Information: exact molecular weight prediction of elemental composition of unknown molecules 23 VUOS PARTNER FOR COOPERATION

VUOS Germany cooperation REACH services: Toxicology Ecotoxicology Substance identification 24 Biocompatibility testing of medical devices under ISO 17025: Hemostatic wound dressing for topical application 24 VUOS PARTNER FOR COOPERATION

Qualification of our staff National Coordinator of the OECD Test Guidelines Programme Representative of the Ministry of Environment of the Czech Republic in OECD Joint Meeting of the Chemicals Committee and the 25 Working Party on Chemicals, Pesticides and Biotechnology Committee member at the Ministry of Health of the Czech Republic for the protection of animals used for scientific purposes Members of the Federation of Laboratory Animal Science Associations (FELASA) 25 VUOS PARTNER FOR COOPERATION

Why to choose VUOS? Responsive and efficient High quality service Experienced staff Flexibility and adaptability 26 Full service for REACH registration R&D services GLP, GMP, ISO 17025, ISO 9001 compliant 26 VUOS PARTNER FOR COOPERATION

Contacts General Manager: Dr. Karel Novák Phone: +420 46 682 2550, e-mail: karel.novak@vuos.com Sales Manager: Miloš Jesenský, Ph.D. Phone: +420 46 682 3300, e-mail: milos.jesensky@vuos.com R&D: Alois Koloničný, Ph.D. 27 Phone:+420 46 682 3156, e-mail: alois.kolonicny@vuos.com Toxicology and Analytics: Michal Bartoš Phone:+420 46 682 2501, e-mail: michal.bartos@vuos.com 27 VUOS PARTNER FOR COOPERATION

PARTNER FOR COOPERATION 28 28